nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—BCHE—diaphragm—thymus cancer	0.0486	0.121	CbGeAlD
Mefloquine—Breast feeding—Octreotide—thymus cancer	0.039	0.0651	CcSEcCtD
Mefloquine—HBA2—neck—thymus cancer	0.0311	0.0774	CbGeAlD
Mefloquine—Appetite absent—Octreotide—thymus cancer	0.0274	0.0457	CcSEcCtD
Mefloquine—HBA1—hematopoietic system—thymus cancer	0.0252	0.0628	CbGeAlD
Mefloquine—Loose stools—Octreotide—thymus cancer	0.0246	0.0411	CcSEcCtD
Mefloquine—Pregnancy—Octreotide—thymus cancer	0.024	0.0401	CcSEcCtD
Mefloquine—HBA2—hematopoietic system—thymus cancer	0.0231	0.0576	CbGeAlD
Mefloquine—HBA2—epithelium—thymus cancer	0.0211	0.0527	CbGeAlD
Mefloquine—Paranoia—Octreotide—thymus cancer	0.02	0.0333	CcSEcCtD
Mefloquine—Influenza-like symptoms—Octreotide—thymus cancer	0.0191	0.0318	CcSEcCtD
Mefloquine—Neuritis—Octreotide—thymus cancer	0.0182	0.0304	CcSEcCtD
Mefloquine—HBA1—lymphoid tissue—thymus cancer	0.0177	0.0442	CbGeAlD
Mefloquine—HBA2—lymphoid tissue—thymus cancer	0.0163	0.0406	CbGeAlD
Mefloquine—HBA1—bone marrow—thymus cancer	0.0161	0.0402	CbGeAlD
Mefloquine—HBA2—bone marrow—thymus cancer	0.0148	0.0369	CbGeAlD
Mefloquine—HBA2—thyroid gland—thymus cancer	0.0148	0.0368	CbGeAlD
Mefloquine—Drug interaction—Octreotide—thymus cancer	0.0147	0.0245	CcSEcCtD
Mefloquine—HBA1—lung—thymus cancer	0.0146	0.0364	CbGeAlD
Mefloquine—Hearing impaired—Octreotide—thymus cancer	0.0143	0.0239	CcSEcCtD
Mefloquine—HBA2—lung—thymus cancer	0.0134	0.0335	CbGeAlD
Mefloquine—Influenza like illness—Octreotide—thymus cancer	0.0132	0.0221	CcSEcCtD
Mefloquine—Neuropathy—Octreotide—thymus cancer	0.0128	0.0213	CcSEcCtD
Mefloquine—ADORA2A—hematopoietic system—thymus cancer	0.012	0.03	CbGeAlD
Mefloquine—Sleep disorder—Octreotide—thymus cancer	0.0114	0.0191	CcSEcCtD
Mefloquine—Deafness—Octreotide—thymus cancer	0.011	0.0184	CcSEcCtD
Mefloquine—Visual disturbance—Octreotide—thymus cancer	0.0104	0.0174	CcSEcCtD
Mefloquine—ADORA1—hematopoietic system—thymus cancer	0.0104	0.0259	CbGeAlD
Mefloquine—HBA1—lymph node—thymus cancer	0.01	0.0249	CbGeAlD
Mefloquine—Psychotic disorder—Octreotide—thymus cancer	0.00965	0.0161	CcSEcCtD
Mefloquine—Irritability—Octreotide—thymus cancer	0.00943	0.0157	CcSEcCtD
Mefloquine—HBA2—lymph node—thymus cancer	0.00918	0.0229	CbGeAlD
Mefloquine—Cramp muscle—Octreotide—thymus cancer	0.0089	0.0149	CcSEcCtD
Mefloquine—Muscular weakness—Octreotide—thymus cancer	0.00871	0.0146	CcSEcCtD
Mefloquine—ADORA2A—lymphoid tissue—thymus cancer	0.00847	0.0211	CbGeAlD
Mefloquine—ADORA1—cardiac atrium—thymus cancer	0.00789	0.0197	CbGeAlD
Mefloquine—Pneumonia—Octreotide—thymus cancer	0.00766	0.0128	CcSEcCtD
Mefloquine—Neuropathy peripheral—Octreotide—thymus cancer	0.00746	0.0125	CcSEcCtD
Mefloquine—Hepatobiliary disease—Octreotide—thymus cancer	0.0072	0.012	CcSEcCtD
Mefloquine—CYP19A1—hematopoietic system—thymus cancer	0.00705	0.0176	CbGeAlD
Mefloquine—Bradycardia—Octreotide—thymus cancer	0.00696	0.0116	CcSEcCtD
Mefloquine—ADORA1—thyroid gland—thymus cancer	0.00664	0.0166	CbGeAlD
Mefloquine—ACHE—thyroid gland—thymus cancer	0.0066	0.0165	CbGeAlD
Mefloquine—Visual impairment—Octreotide—thymus cancer	0.00659	0.011	CcSEcCtD
Mefloquine—Tinnitus—Octreotide—thymus cancer	0.00637	0.0106	CcSEcCtD
Mefloquine—Cardiac disorder—Octreotide—thymus cancer	0.00634	0.0106	CcSEcCtD
Mefloquine—Flushing—Octreotide—thymus cancer	0.00634	0.0106	CcSEcCtD
Mefloquine—Alopecia—Octreotide—thymus cancer	0.00604	0.0101	CcSEcCtD
Mefloquine—ADORA1—lung—thymus cancer	0.00603	0.015	CbGeAlD
Mefloquine—Mental disorder—Octreotide—thymus cancer	0.00599	0.01	CcSEcCtD
Mefloquine—Malnutrition—Octreotide—thymus cancer	0.00595	0.00994	CcSEcCtD
Mefloquine—Erythema—Octreotide—thymus cancer	0.00595	0.00994	CcSEcCtD
Mefloquine—Muscle spasms—Octreotide—thymus cancer	0.00572	0.00955	CcSEcCtD
Mefloquine—Vision blurred—Octreotide—thymus cancer	0.00561	0.00936	CcSEcCtD
Mefloquine—Tremor—Octreotide—thymus cancer	0.00557	0.00931	CcSEcCtD
Mefloquine—Ill-defined disorder—Octreotide—thymus cancer	0.00552	0.00922	CcSEcCtD
Mefloquine—Agitation—Octreotide—thymus cancer	0.00547	0.00913	CcSEcCtD
Mefloquine—Malaise—Octreotide—thymus cancer	0.00537	0.00896	CcSEcCtD
Mefloquine—Vertigo—Octreotide—thymus cancer	0.00535	0.00893	CcSEcCtD
Mefloquine—Syncope—Octreotide—thymus cancer	0.00534	0.00891	CcSEcCtD
Mefloquine—Palpitations—Octreotide—thymus cancer	0.00526	0.00878	CcSEcCtD
Mefloquine—Loss of consciousness—Octreotide—thymus cancer	0.00523	0.00873	CcSEcCtD
Mefloquine—Convulsion—Octreotide—thymus cancer	0.00515	0.00861	CcSEcCtD
Mefloquine—Hypertension—Octreotide—thymus cancer	0.00514	0.00858	CcSEcCtD
Mefloquine—BCHE—hematopoietic system—thymus cancer	0.00507	0.0126	CbGeAlD
Mefloquine—Arthralgia—Octreotide—thymus cancer	0.00507	0.00846	CcSEcCtD
Mefloquine—Chest pain—Octreotide—thymus cancer	0.00507	0.00846	CcSEcCtD
Mefloquine—Myalgia—Octreotide—thymus cancer	0.00507	0.00846	CcSEcCtD
Mefloquine—Anxiety—Octreotide—thymus cancer	0.00505	0.00843	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00503	0.0084	CcSEcCtD
Mefloquine—Discomfort—Octreotide—thymus cancer	0.005	0.00836	CcSEcCtD
Mefloquine—Oedema—Octreotide—thymus cancer	0.00486	0.00811	CcSEcCtD
Mefloquine—Anaphylactic shock—Octreotide—thymus cancer	0.00486	0.00811	CcSEcCtD
Mefloquine—Shock—Octreotide—thymus cancer	0.00478	0.00798	CcSEcCtD
Mefloquine—Nervous system disorder—Octreotide—thymus cancer	0.00476	0.00795	CcSEcCtD
Mefloquine—Thrombocytopenia—Octreotide—thymus cancer	0.00475	0.00794	CcSEcCtD
Mefloquine—Tachycardia—Octreotide—thymus cancer	0.00474	0.00791	CcSEcCtD
Mefloquine—Skin disorder—Octreotide—thymus cancer	0.00472	0.00788	CcSEcCtD
Mefloquine—Hyperhidrosis—Octreotide—thymus cancer	0.00469	0.00784	CcSEcCtD
Mefloquine—CYP19A1—thyroid gland—thymus cancer	0.00451	0.0112	CbGeAlD
Mefloquine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00442	0.00739	CcSEcCtD
Mefloquine—Insomnia—Octreotide—thymus cancer	0.00439	0.00733	CcSEcCtD
Mefloquine—Paraesthesia—Octreotide—thymus cancer	0.00436	0.00728	CcSEcCtD
Mefloquine—Dyspnoea—Octreotide—thymus cancer	0.00433	0.00723	CcSEcCtD
Mefloquine—Somnolence—Octreotide—thymus cancer	0.00432	0.00721	CcSEcCtD
Mefloquine—Dyspepsia—Octreotide—thymus cancer	0.00427	0.00714	CcSEcCtD
Mefloquine—Decreased appetite—Octreotide—thymus cancer	0.00422	0.00705	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00419	0.007	CcSEcCtD
Mefloquine—Fatigue—Octreotide—thymus cancer	0.00419	0.00699	CcSEcCtD
Mefloquine—ADORA1—lymph node—thymus cancer	0.00413	0.0103	CbGeAlD
Mefloquine—ACHE—lymph node—thymus cancer	0.0041	0.0102	CbGeAlD
Mefloquine—Feeling abnormal—Octreotide—thymus cancer	0.004	0.00668	CcSEcCtD
Mefloquine—Gastrointestinal pain—Octreotide—thymus cancer	0.00397	0.00663	CcSEcCtD
Mefloquine—Urticaria—Octreotide—thymus cancer	0.00386	0.00644	CcSEcCtD
Mefloquine—BCHE—cardiac atrium—thymus cancer	0.00385	0.0096	CbGeAlD
Mefloquine—Abdominal pain—Octreotide—thymus cancer	0.00384	0.00641	CcSEcCtD
Mefloquine—Body temperature increased—Octreotide—thymus cancer	0.00384	0.00641	CcSEcCtD
Mefloquine—BCHE—pituitary gland—thymus cancer	0.00376	0.00938	CbGeAlD
Mefloquine—Hypersensitivity—Octreotide—thymus cancer	0.00358	0.00597	CcSEcCtD
Mefloquine—Asthenia—Octreotide—thymus cancer	0.00348	0.00582	CcSEcCtD
Mefloquine—Pruritus—Octreotide—thymus cancer	0.00344	0.00574	CcSEcCtD
Mefloquine—CYP3A4—hematopoietic system—thymus cancer	0.00342	0.00852	CbGeAlD
Mefloquine—CYP2D6—hematopoietic system—thymus cancer	0.00336	0.00838	CbGeAlD
Mefloquine—Diarrhoea—Octreotide—thymus cancer	0.00332	0.00555	CcSEcCtD
Mefloquine—BCHE—bone marrow—thymus cancer	0.00325	0.00811	CbGeAlD
Mefloquine—BCHE—thyroid gland—thymus cancer	0.00325	0.00809	CbGeAlD
Mefloquine—Dizziness—Octreotide—thymus cancer	0.00321	0.00536	CcSEcCtD
Mefloquine—Vomiting—Octreotide—thymus cancer	0.00309	0.00516	CcSEcCtD
Mefloquine—Rash—Octreotide—thymus cancer	0.00306	0.00511	CcSEcCtD
Mefloquine—Dermatitis—Octreotide—thymus cancer	0.00306	0.00511	CcSEcCtD
Mefloquine—Headache—Octreotide—thymus cancer	0.00304	0.00508	CcSEcCtD
Mefloquine—BCHE—lung—thymus cancer	0.00295	0.00735	CbGeAlD
Mefloquine—Nausea—Octreotide—thymus cancer	0.00288	0.00482	CcSEcCtD
Mefloquine—CYP19A1—lymph node—thymus cancer	0.0028	0.00698	CbGeAlD
Mefloquine—ABCB1—hematopoietic system—thymus cancer	0.00242	0.00603	CbGeAlD
Mefloquine—ABCB1—epithelium—thymus cancer	0.00221	0.00551	CbGeAlD
Mefloquine—BCHE—lymph node—thymus cancer	0.00202	0.00502	CbGeAlD
Mefloquine—ABCB1—pituitary gland—thymus cancer	0.00179	0.00447	CbGeAlD
Mefloquine—ABCB1—lymphoid tissue—thymus cancer	0.0017	0.00424	CbGeAlD
Mefloquine—ABCB1—bone marrow—thymus cancer	0.00155	0.00386	CbGeAlD
Mefloquine—ABCB1—thyroid gland—thymus cancer	0.00155	0.00385	CbGeAlD
Mefloquine—ABCB1—lung—thymus cancer	0.0014	0.0035	CbGeAlD
Mefloquine—ABCB1—lymph node—thymus cancer	0.000961	0.00239	CbGeAlD
